homepage_cover_1

Firm of Choice
for the Most Difficult
Legal Issues

homepage_cover_2

Cross-Border Capabilities
with a China Edge

News

Fangda advised Kangh in reaching an exclusive license agreement with HilleVax for the Recombinant Hexavalent VLP Norovirus Vaccine

Insight

Antitrust China Annual Review 2023
Our annual review examines ten significant trends in China's antitrust landscape in 2023 and presents the forecasts for 2024.

Awards & Rankings

The Legal 500 Asia-Pacific 2024
Tier 1 Rankings

Chambers Greater China Region Guide 2023
Band 1 Rankings